OSTX

Os Therapies Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Value↓ 4/10
Os Therapies sales and earnings growth
OSTX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 14.29%
  • FCF Y/Y↓ -52.35%
Os Therapies gross and profit margin trends
OSTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 0.00%
Os Therapies net debt vs free cash flow
OSTX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -467.2

Os Therapies stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks